Such glycosylations can extend CD146 protein stability, upregulate CD146 protein levels, and lead to elevation of CD146-mediated cellular motility in melanoma cells.26 These observations suggest that the degree of CD146 glycosylation may be directly related to malignant progression of tumors, especially CD146-positive neoplasms. This evidence concerns the gene MCAM and neoplasm.